Vertex Pharmaceuticals (VRTX) EBIT Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.47% |
| Dec 31, 2025 | 5.28% |
| Sep 30, 2025 | 1.73% |
| Jun 30, 2025 | 1.33% |
| Mar 31, 2025 | -15.41% |
| Dec 31, 2024 | 5.34% |
| Sep 30, 2024 | 1.92% |
| Jun 30, 2024 | -352.64% |
| Mar 31, 2024 | 8.68% |
| Dec 31, 2023 | 9.85% |
| Sep 30, 2023 | 15.59% |
| Jun 30, 2023 | 12.65% |
| Mar 31, 2023 | 2.65% |
| Dec 31, 2022 | 23.29% |
| Sep 30, 2022 | 124.68% |
| Jun 30, 2022 | 60.03% |
| Mar 31, 2022 | 55.50% |
| Dec 31, 2021 | 90.12% |
| Sep 30, 2021 | 72.44% |
| Jun 30, 2021 | -30.44% |
| Mar 31, 2021 | 90.26% |
| Dec 31, 2020 | 81.02% |
| Sep 30, 2020 | 59.55% |
| Jun 30, 2020 | 138.83% |
| Mar 31, 2020 | 38.54% |
| Dec 31, 2019 | 140.51% |
| Sep 30, 2019 | 94.03% |
| Jun 30, 2019 | 331.81% |
| Mar 31, 2019 | 177.27% |
| Dec 31, 2018 | 63.59% |
| Sep 30, 2018 | 70.27% |
| Jun 30, 2018 | 44.39% |
| Mar 31, 2018 | 40.09% |
| Dec 31, 2017 | 41.26% |
| Sep 30, 2017 | -31.86% |
| Jun 30, 2017 | 31.85% |
| Mar 31, 2017 | 48.18% |
| Dec 31, 2016 | 80.24% |
| Sep 30, 2016 | 46.68% |
| Jun 30, 2016 | 27.47% |
| Mar 31, 2016 | 67.80% |
| Dec 31, 2015 | 11.50% |
| Sep 30, 2015 | -302.86% |
| Jun 30, 2015 | -151.42% |
| Mar 31, 2015 | -57.09% |
| Dec 31, 2014 | -39.01% |
| Sep 30, 2014 | -38.54% |
| Mar 31, 2014 | -10.55% |
| Dec 31, 2013 | 60.49% |
| Sep 30, 2013 | 14.77% |
| Jun 30, 2013 | 34.79% |
| Mar 31, 2013 | -38.86% |
| Dec 31, 2012 | 19.17% |
| Sep 30, 2012 | 80.67% |
| Jun 30, 2012 | 59.08% |
| Mar 31, 2012 | 36.91% |